1. The document discusses a gene therapy trial for X-linked severe combined immunodeficiency (X-SCID) where a retrovirus was used to insert the gamma chain gene into patients' cells. 2. However, in subsequent years some patients developed leukemia due to insertional mutagenesis of the retrovirus activating the LMO2 oncogene, which blocks T-cell differentiation and promotes proliferation. 3. The success of gene therapy depends on transduced cells gaining a growth advantage, but the PEG-ADA therapy for ADA-SCID succeeded because extra ADA expression did not provide an advantage.